In 2023, Argentina reported the highest mortality rate in skin and subcutaneous tissue diseases among women, with a unit value per hundred thousand. European nations like Latvia and Spain followed closely, while countries such as Iceland, Greece, and Slovenia recorded the lowest rates. Over the previous five years, countries like Estonia and Luxembourg experienced significant increases in mortality rates, while Finland and Romania saw noticeable declines. Key drivers for these trends might include demographic shifts, healthcare access, and preventive measures. Portugal exhibited the most significant year-over-year increase, suggesting emerging health challenges in managing such diseases.
Future trends to monitor include the impact of advancements in dermatological treatments, awareness campaigns targeting skin health, and varying public health strategies. The aging population and climate change may also influence disease patterns and mortality rates. Understanding these factors is essential for addressing skin and subcutaneous tissue diseases globally.
Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Argentina | 8.4 | 2023 | +6.33% | +2.85% | View data |
| 2 | 2 Latvia | 5.6 | 2023 | +3.7% | -0.35% | View data |
| 3 | 3 Spain | 5.4 | 2023 | +1.89% | +1.55% | View data |
| 4 | 4 Portugal | 5.2 | 2023 | +6.12% | +18.77% | View data |
| 5 | 5 Slovakia | 5.1 | 2023 | +2% | +2.09% | View data |
| 6 | 6 Chile | 5.1 | 2023 | 0% | 0% | View data |
| 7 | 7 United Kingdom | 4.4 | 2023 | +2.33% | +0.93% | View data |
| 8 | 8 Brazil | 4.1 | 2023 | +5.13% | +4.44% | View data |
| 9 | 9 Mexico | 4 | 2023 | +11.11% | +4.56% | View data |
| 10 | 10 Belgium | 3.8 | 2023 | -2.56% | -0.52% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...